Utilizing a variety of methods including injections, peels, and topical treatments, we can help transform your skin safely and effectively
Yes, the FDAs black box warning for medullary thyroid carcinoma and MEN 2 syndrome applies to the entire class of GLP-1 receptor agonists, which include liraglutide (Saxeda and Victoza), dulaglutide (Trulicity), semaglutide (Ozempic, Rybelsus, and Wegovy), and tirzepatide (Mounjaro and Zepbound)
They may also recommend interventional radiology image-guided procedures to block the bleeding vessel if they cannot reach or control the source of bleeding but they can target the source with imaging
Studies consistently show that patients regain most of the weight within a year of stopping
Ive heard about GLP-1s negative side effects